Member Info for Harrogate4

--------seems a complete plucker to me.

Your spelling indicates you are still on the fine wine.

Voted No 514,868 shares (Interactive Investor)

Would be good to get lots of things, and my money is on Dr Coughlin to shake this up a bit, in true American fashion, because someone needs to do it.

Just a week now until Dr Coughlin takes up position as Executive Director and Head of R&D, and I welcome her arrival and wish her all the best for her time at Avacta.

Hopefully she has some smart ideas as to how to lift the share price up from its long term state of lethargic inertia and it wouldn't surprise me if she does.

Timster

" You just tell the FDA what you are doing, carry on and if the FDA decide they don't like it they tell you to stop ."

So, confirmation from Avacta that the FDA haven't told them to stop would be nice. It's still what Comms were made for.

I assume they walked the FDA approval.

So do I, but confirmation from Avacta would be nice. It's what Comms were made for.

Here's their reply to my complaint.

"Thank you for your email, copied below, regarding Shanta Gold Limited (the "Company") and the proposed acquisition of the Company by Saturn Resources Ltd, a wholly-owned subsidiary of ETC Holdings (Mauritius Limited), (the “proposed acquirer”).

AIM Regulation considers all enquiries as regards the conduct Thank you for your email, copied below, regarding Shanta Gold Limited (the "Company") and the proposed acquisition of the Company by Saturn Resources Ltd, a wholly-owned subsidiary of ETC Holdings (Mauritius Limited), (the “proposed acquirer”).

AIM Regulation considers all enquiries as regards the conduct of AIM companies and nominated advisers in respect of their compliance with the AIM Rules for Companies (“AIM Rules”) and for Nominated Advisers (“Nomad Rules”), and takes action where appropriate. Please note that AIM Regulation's remit does not extend beyond the AIM Rules and Nomad Rules. Further information regarding the remit of AIM Regulation, and that of other regulators and competent authorities, can be found at the following: AIM Regulatory Landscape.

We note your indication that, amongst other matters, you are dissatisfied with: (i) the proposed acquisition price per share which you suggest undervalues the Company; and (ii) the involvement and interest of one of the Company’s non-executive directors (Mr Ketan Patel) in the proposed acquirer; and (iii) the Company’s decision to recommend the acquisition to shareholders.

In this regard please note that agreeing the terms of a potential offer and a decision to recommend that shareholders accept it are primarily matters for the particular AIM company’s Board to consider, having regard to relevant legal duties and obligations. However, if you have not done so already, it may be of assistance to you to note that the Company has confirmed in its notification of 20 December 2023, amongst other matters, how it is managing conflicts through independent directors recommendations.

Further, you may wish to note that it is open to shareholders to vote against the proposal with, shareholder approval of the proposed acquisition conditional upon 75% majority shareholder resolutions. Further details of these arrangements and dates of the meetings will be included in the Scheme Document, due to be published in January 2024.

As indicated, we can assure you that we consider all enquiries and investigate alleged breaches of our rules. Accordingly, if you have specific concerns over the Company’s compliance with the AIM Rules or the nominated adviser’s compliance with the Nomad Rules please provide details to aimregulation@lseg.com. However, you will appreciate that confidentiality is essential in maintaining the integrity of our work and, accordingly, please note we are unable to comment on company specific matters.

We trust the above is of assistance to you.

Kind regards

AIM REGULATION"

MattyBoy1965 -----Eloquently put and true.

BuenaVista -----do we have any details as to whether CC will need to transfer to the UK when she takes up the Head of R & D etc post on 1st February, or whether she can WFH in the States?

ThePublican777 ------Agree with you that if the Chinese (or anybody else for that matter ) don't go for this, then there is stuff we don't know because we haven't been told.

That's another breach of the AIM Rules by the way .

Better ( left out)

Macaumike ----What can be done is report it to aimregulation@londonstockexchange.com as I have done. The more on here that do it the . Report it as a breach of AIM rules and not acting in the SH's interest.

1755 -----We appear to be on the same page, and most shareholders who contribute to this board seem prepared to vote No regarding the derisory Patel offer. No doubt Patel et al would be overjoyed to buy Shanta at such a low price, but the name of the game is to stop that happening either via alternative buy out proposals from other parties, or by Patel et al increasing their inadequate and derisory offer to a more acceptable level. I see this going above the offer price.

1755, ----Agree with you on the money printing which in a sane world should equate to stronger gold, but the Shanta BOD's duty under the AIM Rules is to do the best for its shareholders, which isn't reflected in the derisory Patel offer of 13.5p per share being called a "good deal for shareholders".

Flippineck ---Thanks

Shreeram? Any further or better particulars as to who this is?

2nd February is a Friday.

G_G_G -----agreed and ditto for me.

Got the following back from aimregulation:

"Thank you for your email, copied below, regarding Shanta Gold Limited, which AIM Regulation will consider."

Kind regards

AIM REGULATION

Will let the board know what they say in due course.